-ritide
Natriuretic peptides, which relax blood vessels and increase salt excretion.
- Drugs ending in -ritide: 6
- Approved somewhere: 2
- With a US drug page: 3
- Stem
- -ritide
- Class
- Natriuretic peptides, which relax blood vessels and increase salt excretion
- Most common targets
- NPR1 (1), NPR2 (1), Atrial natriuretic peptide receptor (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -ritide, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Nesiritide | Approved | NPR1 | Atrial natriuretic peptide receptor A agonist |
| Vosoritide | Approved | NPR2 | Atrial natriuretic peptide receptor B binding agent |
| Navepegritide | Phase 2 | — | — |
| Ularitide | Phase 3 | — | — |
| Cenderitide | Phase 2 | — | — |
| Carperitide | — | Atrial natriuretic peptide receptor | Atrial natriuretic peptide receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO